Eli Lilly starts human study of potential COVID-19 treatment

(Reuters) – Eli Lilly and Co said on Monday patients have been dosed to test its potential antibody treatment designed to fight COVID-19, caused by the new coronavirus.

The study will assess safety and tolerability in patients hospitalized with COVID-19 and results are anticipated by the end of June, the company said in a statement.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)